Story excerpt provided by Dayton Business Journal.
Written by Tristan Navera.
AtriCure announced Monday that 2015 beat its aggressive expectations.
AtriCure (NYSE: ATRC) said it finished its fourth quarter with an estimated $35.9 million in revenue — a 21.9 percent growth on the year. This as it says its full 2015 revenue is at $129.8 million, a growth of 20.8 percent compared to 2014.
Click here to read the complete article.
Originally published January 11, 2016.